<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008517.ref024">
 <label>24</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Pal</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Dowd</surname>
   <given-names>KA</given-names>
  </name>, 
  <name>
   <surname>Brien</surname>
   <given-names>JD</given-names>
  </name>, 
  <name>
   <surname>Edeling</surname>
   <given-names>MA</given-names>
  </name>, 
  <name>
   <surname>Gorlatov</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Johnson</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus</article-title>. 
  <source>PLoS Pathog</source>. 
  <year>2013</year>;
  <volume>9</volume>: 
  <fpage>e1003312</fpage>
  <pub-id pub-id-type="doi">10.1371/journal.ppat.1003312</pub-id>
  <?supplied-pmid 23637602?>
  <pub-id pub-id-type="pmid">23637602</pub-id>
 </mixed-citation>
</ref>
